These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 38104110)

  • 21. The prognostic role of long noncoding RNA CRNDE in cancer patients: a systematic review and meta-analysis.
    Wang W; Yuan F; Xu J
    Neoplasma; 2019 Jan; 66(1):73-82. PubMed ID: 30509091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long noncoding RNA PVT1, a novel promising biomarker to predict lymph node metastasis and prognosis: a meta-analysis.
    Liu FT; Xue QZ; Zhu ZM; Qiu C; Hao TF; Zhu PQ; Luo HL
    Panminerva Med; 2016 Jun; 58(2):160-6. PubMed ID: 26882847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic and clinicopathological value of long noncoding RNA XIST in cancer.
    Zhu J; Kong F; Xing L; Jin Z; Li Z
    Clin Chim Acta; 2018 Apr; 479():43-47. PubMed ID: 29307668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of lncRNA FEZF1 antisense RNA 1 over-expression in oncologic outcomes of patients with solid tumors.
    Zhang Y; Yang QX; Peng TT; Wang LJ; Xiao GL; Tang SB
    Medicine (Baltimore); 2019 Jun; 98(24):e15982. PubMed ID: 31192939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High BANCR expression is associated with worse prognosis in human malignant carcinomas: an updated systematic review and meta-analysis.
    Fang S; Liu Z; Guo Q; Chen C; Ke X; Xu G
    BMC Cancer; 2020 Sep; 20(1):870. PubMed ID: 32907530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long non-coding RNA NEAT1 overexpression is associated with poor prognosis in cancer patients: a systematic review and meta-analysis.
    Yang C; Li Z; Li Y; Xu R; Wang Y; Tian Y; Chen W
    Oncotarget; 2017 Jan; 8(2):2672-2680. PubMed ID: 27926523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TP73-AS1 as a predictor of clinicopathological parameters and prognosis in human malignancies: a meta and bioinformatics analysis.
    Chen C; Wang J; Feng Y; Liang Y; Huang Y; Zou W
    BMC Cancer; 2022 May; 22(1):581. PubMed ID: 35614413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LINC00511 as a prognostic biomarker for human cancers: a systematic review and meta-analysis.
    Agbana YL; Abi ME; Ni Y; Xiong G; Chen J; Yun F; Yi Z; Zhang Q; Yang Z; Kuang Y; Zhu Y
    BMC Cancer; 2020 Jul; 20(1):682. PubMed ID: 32698787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic and clinical significance of long non-coding RNA HNF1A-AS1 in solid cancers: A systematic review and meta-analysis.
    Zhou X; Fan YH; Wang Y; Liu Y
    Medicine (Baltimore); 2019 Dec; 98(49):e18264. PubMed ID: 31804362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. XIST as a valuable biomarker for prognosis and clinical parameters in diverse tumors: a comprehensive meta- and bioinformatics analysis.
    Zhang MJ; Yan Z; Qin J; Luo TH; Yang B
    Neoplasma; 2022 Sep; 69(5):1217-1227. PubMed ID: 35900315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of long noncoding RNA UCA1 as a common molecular marker for lymph node metastasis and prognosis in various cancers: a meta-analysis.
    He A; Hu R; Chen Z; Liao X; Li J; Wang D; Lv Z; Liu Y; Wang F; Mei H
    Oncotarget; 2017 Jan; 8(1):1937-1943. PubMed ID: 27713161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognostic value of lncRNA AGAP2-AS1 in cancer patients: A meta-analysis.
    Zhong P; Hua H; Chen S; Zhu Z; Xie F
    Medicine (Baltimore); 2021 Dec; 100(51):e28425. PubMed ID: 34941192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic Value of Long Noncoding RNA CRNDE as a Novel Biomarker in Solid Cancers: An Updated Systematic Review and Meta-Analysis.
    Zhou Y; Wang R; Xu T; Xie P; Zhang Y; Zhang A; Wang X; Yang C; Yang H; Zhu S
    J Cancer; 2019; 10(11):2386-2396. PubMed ID: 31258743
    [No Abstract]   [Full Text] [Related]  

  • 34. Decreased expression of lncRNA loc285194 as an independent prognostic marker in cancer: A systematic review and meta-analysis.
    Mehrad-Majd H; Ravanshad S; Moradi A; Khansalar N; Sheikhi M; Akhtari J
    Pathol Res Pract; 2019 Jun; 215(6):152426. PubMed ID: 31054796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intratumoral high endothelial venules in solid tumors: a pooled study.
    Wang B; Han Y; Liu J; Zhang X; Deng Y; Jiang Y
    Front Immunol; 2024; 15():1401118. PubMed ID: 39040120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA PANDAR as a prognostic marker in Chinese cancer.
    Ma PJ; Guan QK; Xu DW; Zhao J; Qin N; Jin BZ
    Clin Chim Acta; 2017 Dec; 475():172-177. PubMed ID: 29066211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long Non-Coding RNA TUG1 as a Potential Novel Biomarker for Predicting the Clinical Outcome of Cancer Patients: a Meta-Analysis.
    Li B; Shen S; Zhang W; Qi T; Hu Q; Cheng Y
    Clin Lab; 2018 Oct; 64(11):. PubMed ID: 30549987
    [No Abstract]   [Full Text] [Related]  

  • 38. LncRNA HEIH expression in cancer prognosis: A review and meta-analysis.
    Wang X; Chen Z; Zhou H; Liu W; Luo J
    Medicine (Baltimore); 2023 Jun; 102(22):e33970. PubMed ID: 37266624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of long noncoding RNA ROR in patients with cancer in China: A systematic review and meta-analysis.
    Li S; Yue XC; Sun CY; Qin HY; Zhang XY
    Medicine (Baltimore); 2019 May; 98(21):e15758. PubMed ID: 31124961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrated Analysis Reveals That Long Non-Coding RNA TUBA4B Can Be Used as a Prognostic Biomarker in Various Cancers.
    Zhang T; Wu DM; Deng SH; Han R; Liu T; Li J; Xu Y
    Cell Physiol Biochem; 2018; 49(2):530-544. PubMed ID: 30157490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.